First Time Loading...

Genetec Corp
TSE:4492

Watchlist Manager
Genetec Corp Logo
Genetec Corp
TSE:4492
Watchlist
Price: 978 JPY -2% Market Closed
Updated: Apr 25, 2024

Intrinsic Value

4492 doesn't have a meaningful market cap.

Genetec Corp. engages in the development of embedded software and hardware systems, mobile communications, automotive and digital consumer electronics. [ Read More ]

The intrinsic value of one Genetec Corp stock under the Base Case scenario is 602.53 JPY. Compared to the current market price of 978 JPY, Genetec Corp is Overvalued by 38%.

Key Points:
Intrinsic Value
Base Case
602.53 JPY
Overvaluation 38%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Genetec Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling Genetec Corp stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Genetec Corp

Provide an overview of the primary business activities
of Genetec Corp.

What unique competitive advantages
does Genetec Corp hold over its rivals?

What risks and challenges
does Genetec Corp face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Genetec Corp.

Provide P/S
for Genetec Corp.

Provide P/E
for Genetec Corp.

Provide P/OCF
for Genetec Corp.

Provide P/FCFE
for Genetec Corp.

Provide P/B
for Genetec Corp.

Provide EV/S
for Genetec Corp.

Provide EV/GP
for Genetec Corp.

Provide EV/EBITDA
for Genetec Corp.

Provide EV/EBIT
for Genetec Corp.

Provide EV/OCF
for Genetec Corp.

Provide EV/FCFF
for Genetec Corp.

Provide EV/IC
for Genetec Corp.

What are the Revenue projections
for Genetec Corp?

How accurate were the past Revenue estimates
for Genetec Corp?

What are the Net Income projections
for Genetec Corp?

How accurate were the past Net Income estimates
for Genetec Corp?

What are the EPS projections
for Genetec Corp?

How accurate were the past EPS estimates
for Genetec Corp?

What are the EBIT projections
for Genetec Corp?

How accurate were the past EBIT estimates
for Genetec Corp?

Compare the revenue forecasts
for Genetec Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Genetec Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Genetec Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Genetec Corp compared to its peers.

Compare the P/E ratios
of Genetec Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Genetec Corp with its peers.

Analyze the financial leverage
of Genetec Corp compared to its main competitors.

Show all profitability ratios
for Genetec Corp.

Provide ROE
for Genetec Corp.

Provide ROA
for Genetec Corp.

Provide ROIC
for Genetec Corp.

Provide ROCE
for Genetec Corp.

Provide Gross Margin
for Genetec Corp.

Provide Operating Margin
for Genetec Corp.

Provide Net Margin
for Genetec Corp.

Provide FCF Margin
for Genetec Corp.

Show all solvency ratios
for Genetec Corp.

Provide D/E Ratio
for Genetec Corp.

Provide D/A Ratio
for Genetec Corp.

Provide Interest Coverage Ratio
for Genetec Corp.

Provide Altman Z-Score Ratio
for Genetec Corp.

Provide Quick Ratio
for Genetec Corp.

Provide Current Ratio
for Genetec Corp.

Provide Cash Ratio
for Genetec Corp.

What is the historical Revenue growth
over the last 5 years for Genetec Corp?

What is the historical Net Income growth
over the last 5 years for Genetec Corp?

What is the current Free Cash Flow
of Genetec Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Genetec Corp.

Financials

Balance Sheet Decomposition
Genetec Corp

Current Assets 2.8B
Cash & Short-Term Investments 1.1B
Receivables 1.5B
Other Current Assets 291.6m
Non-Current Assets 1.2B
Long-Term Investments 1.7m
PP&E 103.1m
Intangibles 808.2m
Other Non-Current Assets 312.2m
Current Liabilities 1.5B
Accounts Payable 270.2m
Accrued Liabilities 141.1m
Short-Term Debt 500m
Other Current Liabilities 576.8m
Non-Current Liabilities 548.8m
Long-Term Debt 195m
Other Non-Current Liabilities 353.8m
Efficiency

Earnings Waterfall
Genetec Corp

Revenue
6.9B JPY
Cost of Revenue
-4.1B JPY
Gross Profit
2.8B JPY
Operating Expenses
-2.2B JPY
Operating Income
605.2m JPY
Other Expenses
-201.4m JPY
Net Income
403.8m JPY

Free Cash Flow Analysis
Genetec Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

Profitability Score
Profitability Due Diligence

Genetec Corp's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
ROE is Increasing
Positive ROE
53/100
Profitability
Score

Genetec Corp's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Genetec Corp's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Low D/E
Long-Term Solvency
81/100
Solvency
Score

Genetec Corp's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Genetec Corp

There are no price targets for Genetec Corp.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
Genetec Corp

1M 1M
-1%
6M 6M
-1%
1Y 1Y
+55%
3Y 3Y
+13%
5Y 5Y
+36%
10Y 10Y
+36%
Annual Price Range
978
52w Low
505.3333
52w High
1 615
Price Metrics
Average Annual Return -4.63%
Standard Deviation of Annual Returns 39.11%
Max Drawdown -69%
Shares Statistics
Market Capitalization 11.1B JPY
Shares Outstanding 11 390 082
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Genetec Corp Logo
Genetec Corp

Country

Japan

Industry

Technology

Market Cap

11.1B JPY

Dividend Yield

1.3%

Description

Genetec Corp. engages in the development of embedded software and hardware systems, mobile communications, automotive and digital consumer electronics. The company is headquartered in Shinjuku, Tokyo-To and currently employs 249 full-time employees. The company went IPO on 2020-03-19. The firm operates through two business segments. The System Development segment provides productivity technologies such as analysis, design and evaluation for embedded software development related to embedded devices such as mobile communications, car electronics and digital home appliances. The Engineering Solutions segment is involved in the acquisition, sale and support of the exclusive distributorship in Japan of the 3D computer-aided design (CAD) / computer-aided manufacturing (CAM) software Mastercam. The firm is also involved in the research and development on the automatic location information notification system Kokodayo at the time of disaster.

Contact

TOKYO-TO
Shinjuku
25F, Shinjuku Iland Tower, 6-5-1, Nishi-Shinjuku
+81362585601.0
http://www.genetec.co.jp/

IPO

2020-03-19

Employees

249

Officers

President, CEO & Chairman of the Board
Mr. Kenji Ueno
Managing Executive Officer, GM of Management Headquarters & Director
Mr. Akihiro Suzuki
Senior Executive Officer, GM of Industrial Solution Headquarters & Director
Chia Matsuno
Executive Officer
Katsuji Shibasaki

See Also

Discover More
What is the Intrinsic Value of one Genetec Corp stock?

The intrinsic value of one Genetec Corp stock under the Base Case scenario is 602.53 JPY.

Is Genetec Corp stock undervalued or overvalued?

Compared to the current market price of 978 JPY, Genetec Corp is Overvalued by 38%.